1510635988
PODCAST-19: FiveThirtyEight on the Novel Coronavirus

Advertise on podcast: PODCAST-19: FiveThirtyEight on the Novel Coronavirus

Rating
★★★★☆
4.3
from
333 reviews
This podcast has
46 episodes
Language
English
Date created
2020/04/28
Latest episode
2021/07/14
Average duration
16 min.
Release period
14 days

Description

FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.

Unlock PODCAST-19: FiveThirtyEight on the Novel Coronavirus podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from PODCAST-19: FiveThirtyEight on the Novel Coronavirus podcast


Pandemics Don't Really End
2021/07/14
But podcasts about them do. We're sad to report this is the final episode of PODCAST-19! It's been so rewarding making a show for you over the past year. In this episode, we discuss why we're closing up shop and why pandemics are so hard to beat.
How The CDC's Blindspots Complicated The Fight Against COVID-19
2021/06/30
The CDC wants to be certain, so it typically waits for a critical mass of scientific evidence before making declarative statements. That takes time. Yet the communication to the public in this pandemic seemed to be worse than normal, and resulted in a huge loss of public trust. Over the past month, we spoke to nearly a dozen scientists who all agreed the CDC could have done better. But the root causes of the CDC’s shortcomings will be hard to fix.
The Lab Leak Commotion
2021/06/02
We have no hard evidence to support the idea that the novel coronavirus was leaked from a lab, let alone a smoking gun to validate that hypothesis. But despite pushback on this story from many scientists and the media early on, it’s back in the news, and many are talking about the possibility of a lab leak. There may be some legitimate reasons to do more digging, but the debate has gotten heated. And when a conversation is centered around controversy, instead of science, we can lose sight of the bigger, more important picture.
Who Should Decide Who Gets To Make COVID-19 Vaccines?
2021/05/22
There's a worldwide shortage of vaccines but plenty of factories standing by to make them. Why is there such a gap between what we need and what we can make? On this week's episode, we explore the surprisingly wild world of pharmaceutical patent law to understand how our system came to be and how it has shaped the pandemic.
How To Make Sure Your Kid Isn't A Superspreader
2021/05/07
Kids can't get a COVID-19 vaccination yet, but they're unlikely to develop serious complications from the disease. But they can still be vectors to spread COVID-19 to others who are likely to get very sick. On this week's episode, we look into how big of a risk unvaccinated kids pose to society, and what parents should keep in mind.
You Might Have Given The Coronavirus To Your Cat
2021/04/28
We've learned time and again that animals can give diseases to humans. We've seen this happen with coronaviruses, the flu, Ebola -- basically most major disease outbreaks in recent memory. But, of course, the reverse is true too: Humans can give viruses, including the novel coronavirus, to animals. FiveThirtyEight’s senior science writer Maggie Koerth wrote about this on the site earlier this week, and she joined PODCAST-19, FiveThirtyEight’s coronavirus podcast, to discuss her work further.
What A Donated Vaccine Can Do
2021/04/22
The United States has a surplus of COVID-19 vaccines — more than enough to vaccinate every adult. Poor countries, however, are still struggling to secure doses. Should those vaccines be sent to countries in need? If not, who will do the sending? And should rich countries profit off the exchange?
The Johnson & Johnson Pause Shows The System Is Working
2021/04/13
Federal health agencies asked states to pause in their use of the Johnson & Johnson vaccine while U.S. officials investigate reports of an extremely rare blood-clotting syndrome that has developed in six people who have received the vaccine. Given how few people are sick, why did the U.S. recommend a pause? And what's it say about how the monitoring system is working?
What The Heck Is Going On With AstraZeneca's Vaccine?
2021/03/26
The AstraZeneca COVID-19 vaccine has been hailed as the world’s vaccine -- it’s inexpensive to produce and doesn’t need super-cold storage like the mRNA vaccines do. But its rollout has been messy. Will its missteps erode the public's (or the FDA's) trust? Maggie Koerth joins to discuss.
How To Overcome Vaccine Hesitancy
2021/03/22
At some point, the U.S. is going to run out of people eager to get the vaccine, and we’ll need to work hard to convert those who are still hesitant or don’t know how to get it. It won’t be the first time we’ve done so. For months, community leaders have been working to overcome transportation challenges, language barriers, and digital divides. We speak to five of those leaders on this week's episode to hear how they convinced people to get the vaccine, and what that might mean for the months to come.
The COVID-19 Endemic
2021/03/06
On this week's show, we discuss what the endgame of the pandemic will be. It likely isn't herd immunity. And if herd immunity isn't the goal, does that change how people should behave once they're vaccinated? We have a science-backed guide for how to evaluate what's risky and what's safe among the vaccinated.
How Variants Complicate Everything
2021/02/19
Coronavirus mutations have complicated our path forward. But that doesn’t mean that our current plan out of the pandemic is futile.

Podcast reviews

Read PODCAST-19: FiveThirtyEight on the Novel Coronavirus podcast reviews


4.3 out of 5
333 reviews
★★★★☆
whatlevelisthis7 2021/05/02
Good, but needs to be more data / science based
This podcast is fine but feels a bit phoned in. I like FiveThirtyEight for its analytical and sometimes contrarian (but always data-backed) takes. Thi...
★★☆☆☆
Debbie66 2021/08/16
Stop with the politics
I am a germaphobe who appreciates good and honest information about this virus . The minute you start with the politics - you’ve lost me!
★☆☆☆☆
Mongrel82 2021/06/07
This is a joke
Read the Vanity Fair article and then listen to the lab leak episode. Obviously has an agenda. Completely laughable.
★★☆☆☆
Nance Schultz 2021/05/08
Questions but not always the answers
A lot of the questions asked were nit actually answered but the moderator would make statements that didn’t actually reflect the answers by provided b...
★★★★☆
Maxim the Magnificent 2020/10/19
More NPR than 538
I enjoy this podcast but find it sometimes has a less data oriented feel than I’d expect from a 538 production, including anecdotal, personal elements...
★☆☆☆☆
BerkeleyGrad08 2021/03/10
Podcast is a joke - dumbed down for idiots
The sing songy tone and personal anecdotes let you know right off the bat this is not a serious podcast.
★★★☆☆
pjk2901 2021/02/16
More science
Wish there was more science based conversation
★★★★★
WhiteguyLuke 2021/01/29
I love this podcast
This podcast gives me information about COVID-19 I don’t get anywhere else. Great guests, great questions. Keep it up!
★☆☆☆☆
D.wett 2020/12/30
Terrible
The worst pod ever. Don’t waste your time unless you’re a sheep
★★☆☆☆
ahayron 2020/10/24
Had some moments but...
Mostly this is more of the mainstream narrative, nothing special. It could have gone so much deeper into data. The few interesting counter-narrative p...
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on PODCAST-19: FiveThirtyEight on the Novel Coronavirus relevant audience podcasts


What do you want to promote?